Media Room Menu
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Jun 8, 2015- ELIXA is the first event-driven cardiovascular outcomes study to provide data for a GLP-1 receptor agonist -
-
May 21, 2015- Includes study in patients who were inadequate responders to, or intolerant of, TNF-alpha inhibitors -
-
May 18, 2015- Phase 3 Clinical Trial in Uncontrolled Persistent Asthma Underway -
-
May 11, 2015Despite CDC recommendations, fewer than 30% of teens received the second vaccination to help protect against meningococcal meningitis; new survey reveals potential reasons why
-
Apr 15, 2015U.S. Patent and Trademark Office Honors Sanofi for its Anti-Malarial Treatment
-
Mar 25, 2015Approval allows children to receive a combination of two recommended vaccinations
-
Mar 19, 2015- Results support resubmission of U.S. New Drug Application in Q3 2015 -
-
Mar 18, 2015Allergy sufferers are encouraged to share the #HappySmells they experience this season
-
Mar 15, 2015- Robust and consistent LDL-C lowering demonstrated with Praluent™ in largest, double-blind, placebo-controlled trial of a PCSK9 inhibitor to date -
-
Feb 18, 2015View the Interactive Maps on www.CholesterolCounts.com for a Snapshot of Cholesterol Awareness Across the U.S.
-
Feb 11, 2015America's Leading National Consumer Research Survey Ranks Gold Bond Products #1 in "U.S. Body Comfort and Relief" and "U.S. Skincare" Categories
-
Jan 20, 2015Further education about hypoglycemia and routinely monitoring blood glucose levels is needed
-
Jan 9, 2015- Primary efficacy endpoints met in two trials of alirocumab administered every four weeks -
-
Jan 6, 2015Awards will provide funding for innovative diabetes researchers
-
Dec 18, 2014Employees and contractors celebrate two decades of delivering essential items to Monroe County Head Start children and families
-
Dec 15, 2014New program will spotlight America’s high cholesterol numbers
-
Dec 12, 2014- The first and only four-strain influenza vaccine option administered intradermally -
-
Dec 2, 2014Sanofi Commitment to Research and Develop TB Treatments, Diagnostics and Vaccines Spans More than 50 Years
-
Nov 19, 2014- All six trials met primary efficacy endpoint -
-
Nov 18, 2014IcyHot SmartRelief System Provides Physical Therapist-Trusted TENS Technology for Persistent, Chronic Back Pain Relief That Starts at the Touch of a Button
-
Nov 11, 2014- Dupilumab Demonstrated Improvement in Lung Function, Reductions of Severe Exacerbations -
-
Nov 3, 2014- Includes New Data Showing Fluzone High-Dose Vaccine More Efficacious Than Standard-Dose Fluzone Vaccine -
-
Oct 16, 2014The two companies will develop a product jointly through phase II
-
Sep 18, 2014More Than $83,000 Raised Benefiting Boys & Girls Clubs of NEPA, Employment Opportunity and Training Center, and Marley’s Mission
-
Sep 17, 2014- Up to $200 Million Collaboration to Support Pioneering Science and New Treatments -
-
Sep 8, 2014Approval aligns with Centers for Disease Control and Prevention's recommendations for meningococcal vaccination
-
Aug 31, 2014- Alirocumab, an investigational treatment for hypercholesterolemia, showed a 62 percent reduction in LDL-C compared to placebo at 24 weeks on top of maximally-tolerated lipid-lowering therapy in ODYSSEY LONG TERM trial -
-
Aug 13, 2014- Study Demonstrates Fluzone High-Dose Vaccine 24.2 Percent More Effective Than Standard-Dose Fluzone Vaccine in Preventing Influenza in Adults 65 Years of Age and Older -
-
Aug 13, 2014- Study Demonstrates Fluzone High-Dose Vaccine 24.2 Percent More Effective Than Standard-Dose Fluzone Vaccine in Preventing Influenza in Adults 65 Years of Age and Older -
-
Aug 12, 2014Generics Division of Sanofi, Winthrop US, to Market the Drug
-
Jul 30, 2014- Primary efficacy endpoints met in all nine new trials of investigational PCSK9 inhibitor -